期刊文献+

阿托伐他汀与氟伐他汀对老年高脂血症强化降脂治疗的疗效和安全性观察 被引量:8

Comparative study of effects and safty of atorvastatin and fluvastatin on aged patients with hyperlipidemia
下载PDF
导出
摘要 目的观察比较阿托伐他汀20mg/d与氟伐他汀80mg/d对老年高脂血症病人的降脂疗效及安全性影响。方法120例老年高脂血症患者以随机数字表法平均分成两组。A组:阿托伐他汀20mg/d;B组:氟伐他汀80mg/d。治疗前、治疗后2、4和8周检查血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、甘油三酯(TG)、谷丙转氨酶(ALT)、肌酸磷酸激酶(CK)。结果A,B两组均能显著降低TC(P<0.01)、LDL-C(P<0.01)、TG(P<0.01),A组作用强于B组(P<0.05);同样A,B两组均能升高HDL-C,终点时比较A组仍优于B组,差异有显著性(P<0.05)。两组均有良好的安全性。结论阿托伐他汀20mg/d与氟伐他汀80mg/d均能显著降低TC、LDL-C和TG水平,升高HDL-C水平;阿托伐他汀20mg/d作用明显优于氟伐他汀80mg/d,两者均有好的安全性。 [Objective] To investgate the effects and the safty of Atorvastatin and Fluvastatin on aged patients with hyperlipidemia. [Method] The 120 patients were divided into two groups randomly. 60 in group A were given orally atorvastatin 20 mg/d, and 60 in the group B were given orally fluvastatin 80 mg/d, respectively; The levels serum total cholesterol(TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol(HDL-C) and triglyceride (TG) were measured following the 2th week, 4th week, 8th week. And the changes of the functions of the patients' liver and kidney, the serum glucose level and the activities of myocardial enzymes in the two groups before and after the treatment were also observed. [Results] In the 2th, 4th, 8th week in group A the TCH levels of the patients were decreased by16.7%, 29.8% and 41.9%; the LDL-C leves were decreased by 30%, 43.2% and 48.6%; the TG levels were decreased by 16.7%, 25% and 41.8%; the HDL-C leves were increased by 1%, 3% and 11.1% respectively; While in the 2th, 4th and 8th week in group B the TCH levels of the patients were decreased by 6.6%, 14.7% and 26.2%, the LDL-C leves were decreased 5.6%, 16.7% and 25%, the TG leves were decreased 8%, 14% and 24%, the HDL-C were increased by 1%, 1%, 5% respectively. On the other side,the standard rate of atorvastatin 20 mg/d and fluvastatin 80 mg/d to decrease the LDL-C levels In the 2th, 4th, 8th week were 51.2%, 88.5%, 93.4%, 27.6%, 45.7%, 71.3%, respectively, there was significantly diffrence in the two groups.The reliability of both two groups was good. [Conclusion] Both atorvastatin 20 mg/d and fluvastatin 80 mg/d are effective and reliable in the treatment of Hyperlipidemia, however, atorvastatin 20 mg/d is superior to fluvastatin 80mg/d.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2005年第14期2205-2207,2209,共4页 China Journal of Modern Medicine
关键词 阿托伐他汀 氟伐他汀 高脂血症 atorvastatin fluvastatin hyperlipidemia
  • 相关文献

参考文献12

  • 1SCHOJANSK, PEINADOOJ, FRUCHART JC, et al. 3-Hydroxy3-methylglutaryl CoA redu-etase inhibitors reduce~rllm trlgtyceride levels through modulation of apollpoprote in C-Ⅲ and lipoprotein lipase[J]. FEBS Lett, 1999, 452: 160-164.
  • 2GOTTO AM, ROSA JC, HUNNINGHAKE D, et al. The cholesterol fats. A symmary of the evidence relating dietary fats, serum cholesterol, and coronary heartdisease[J]. Ciuculation, 1990, 81:172.
  • 3Implication of Recent Clinical Trails for the National Cholesterol Education Program Adult Treatment Panel Ⅲ Guidelines[J]. Circulation, 2004, 110: 1-14.
  • 4Heart protection study collaborative group. MRC / BHF Heart protection study of cholesterol lowering with siravastatin in 20536 high risk individuals: a randomized placebo-controlled Trial[J].Lancet, 2002, 360: 7-22.
  • 5ROBERTS WC. Getting more people on statin[J]. Am J Cardiol, 2002, 90: 683-685.
  • 6ERNST J. SCHAEFER, MD, JUDITH R, et al. Comparisons of Effects of statins(Atorvastatin, Fluvastatin, Lovastatin, Pravastatin,and simvastatin)on fasting and Postprandial Lipoproteins in patients with coronary Heart Disease Versus Control Subjects [J].Am J Cardiol, 2004, 93: 31-39.
  • 7KNATTERUD GL, RONBERG Y, CAMPEAU L, et al. longterm efects on clinical outcomes of aggressive lowering of low density lipomtein cholesteol levels and low does anti-coagulation in the post coronary artery bypass graft trial [J]. Circulation,2000, 102: 157-165.
  • 8SERRUYS PW, FOLEY DP, JACKSON G, et al. A randomized placebo controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angio-plasty:final results of the fluvastatin angiographic restenosis(FLARE)trial[J]. Eur Heart J,1998, 20: 58-69.
  • 9PITY B, WATERS D, BROWN WV, et al. Aggressive lipidlowering therapy compared with angioplasty in stable coronary artery, disease[J]. Atorvastatin versus Revascularization Treatment Investigator[J]. N Engl J Med, 1999, 341: 70-76.
  • 10WEMER N, NICKENIG G, LANFS U. pleiotropic effects of HMG-COA.reductase inhibitious [J]. Basic Res Cardial, 2002,97: 105-116.

同被引文献55

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部